Select Your Region
Americas
Europe
Africa
Global
Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- MORNINGSKY
A clinical trial to compare the safety and effectiveness of AT-527 with placebo in people with mild or moderate COVID-19
Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19
Infectious Diseases COVID-19 COVID-19 Pneumonia
Study results
LPS CV43043 MORNINGSKY Final Results October 2022 English
(PDF, 1.8 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Romania Romanian
(PDF, 0.3 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Brazil Portuguese
(PDF, 0.2 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Denmark Danish
(PDF, 0.4 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Mexico Spanish
(PDF, 0.8 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Argentina Spanish
(PDF, 0.2 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Germany German
(PDF, 0.2 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Switzerland German
(PDF, 0.2 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Ukraine Ukrainian
(PDF, 0.3 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Turkey Turkish
(PDF, 0.3 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Belgium French
(PDF, 0.6 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Switzerland French
(PDF, 0.2 MB)
LPS CV43043 MORNINGSKY Final Results October 2022 Japan Japanese
(PDF, 0.7 MB)
LPS CV43043 MORNINGSKY Final Results November 2022 Portugal Portuguese
(PDF, 0.5 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com